ELISA News and Research

RSS
Immuno-metabolomic signatures that correlate with antigen-specific-T cell response during active COVID-19

Immuno-metabolomic signatures that correlate with antigen-specific-T cell response during active COVID-19

17 Mar 2022
Study reports reduced disease severity in Syrian hamsters during re-infection with SARS-CoV-2 Delta variant

Study reports reduced disease severity in Syrian hamsters during re-infection with SARS-CoV-2 Delta variant

17 Mar 2022
Biomarkers to identify SARS-CoV-2 patients requiring invasive mechanical ventilation

Biomarkers to identify SARS-CoV-2 patients requiring invasive mechanical ventilation

17 Mar 2022
Novel fusion inhibitor blocks SARS-CoV-2 spike-mediated cell-cell fusion

Novel fusion inhibitor blocks SARS-CoV-2 spike-mediated cell-cell fusion

17 Mar 2022
The immunogenicity of homologous and heterologous boosters in adults who received inactivated COVID-19 vaccine six months prior

The immunogenicity of homologous and heterologous boosters in adults who received inactivated COVID-19 vaccine six months prior

17 Mar 2022
Lateral flow assays: The possibilities beyond COVID-19

Lateral flow assays: The possibilities beyond COVID-19

From nanoComposix 17 Mar 2022
Placenta found to demonstrate anti-oxidant activity against COVID-19 in full-term pregnancy

Placenta found to demonstrate anti-oxidant activity against COVID-19 in full-term pregnancy

16 Mar 2022
Convalescent antibodies do not enhance SARS-CoV-2 infection

Convalescent antibodies do not enhance SARS-CoV-2 infection

16 Mar 2022
Identification of linear B cell epitopes in the SARS-CoV-2 proteome that are conserved in humans coronaviruses

Identification of linear B cell epitopes in the SARS-CoV-2 proteome that are conserved in humans coronaviruses

15 Mar 2022
One-step ELISA experiments

One-step ELISA experiments

From AMS Biotechnology 15 Mar 2022
Study explores neutralization of SARS-CoV-2 Omicron variant by subunit vaccine boosters

Study explores neutralization of SARS-CoV-2 Omicron variant by subunit vaccine boosters

14 Mar 2022
Protection against SARS-CoV-2 Omicron variant by hetero-bivalent nanobodies

Protection against SARS-CoV-2 Omicron variant by hetero-bivalent nanobodies

14 Mar 2022
Factors influencing cross-protective serological immunity against SARS-CoV-2 variants in Asians

Factors influencing cross-protective serological immunity against SARS-CoV-2 variants in Asians

14 Mar 2022
Immunobridging study shows immunogenicity in adolescents receiving SARS-CoV-2 mRNA and inactivated vaccines

Immunobridging study shows immunogenicity in adolescents receiving SARS-CoV-2 mRNA and inactivated vaccines

14 Mar 2022
Study finds chimeric mRNA induces potent and broadly acting neutralizing antibodies against SARS-CoV-2 variants

Study finds chimeric mRNA induces potent and broadly acting neutralizing antibodies against SARS-CoV-2 variants

10 Mar 2022
Study isolated largest panel of β-CoV broadly neutralizing antibodies to date

Study isolated largest panel of β-CoV broadly neutralizing antibodies to date

10 Mar 2022
The trajectory of B-cell immunity six months after mRNA vaccination

The trajectory of B-cell immunity six months after mRNA vaccination

10 Mar 2022
Study evaluates heterologous vaccination scheme in children using two SARS-CoV-2 RBD protein vaccines

Study evaluates heterologous vaccination scheme in children using two SARS-CoV-2 RBD protein vaccines

8 Mar 2022
SARS-CoV-2 breakthrough infection leads to distinct neutralizing antibody response

SARS-CoV-2 breakthrough infection leads to distinct neutralizing antibody response

7 Mar 2022
Omicron-specific mRNA vaccine generates immune responses in mice, hamsters and Macaques

Omicron-specific mRNA vaccine generates immune responses in mice, hamsters and Macaques

6 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback